Bristol-Myers gets review for leukemia drug (Crain's New York Business)
Bristol-Myers Squibb said Tuesday that the Food and Drug Administration will do an expedited review of a drug used to treat a chronic form of leukemia that affects about 20,000 adults nationwide.